US HCPs: Stable access for ever-evolving therapies: #MIDWAY 43 tracking to MMA origin as stand-alone support for ONYX embolization of frontal branch. Courtesy of Dr. Dennys Reyes! Rx only. Risk: peninc.info/risk Clinical results may vary.
About us
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. Members of the Penumbra team agree that this is where their work has meaning -- we are transforming the treatment of some of the world's most devastating conditions. Penumbra is where everyone's ideas matter, and where learning and growth are constant. No. 5 on the Greater Bay Area Manufacturers List, San Francisco Business Times, 2020 100 Fastest-Growing Companies, Fortune, 2019 Review our community guidelines for LinkedIn here: https://bit.ly/2Jmbw83.
- Website
-
http://www.penumbrainc.com
External link for Penumbra, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Alameda, CA
- Type
- Public Company
- Founded
- 2004
Locations
-
Primary
One Penumbra Place
Alameda, CA 94502, US
Employees at Penumbra, Inc.
Updates
-
We're live now! Join our webinar to discover how MIDWAY intermediate catheters are designed to revolutionize neurovascular procedures with optimized trackability, support, and stable access for ever-evolving therapies. Don't miss out-click the link to join us now! https://lnkd.in/giWDYi9Y Rx only. Risk: peninc.info/risk Clinical results may vary.
US HCPs: We're just an hour away! Join us soon to explore how MIDWAY intermediate catheters are engineered for trackability, support, and stable access for ever-evolving therapies. Haven't registered yet? There's still time! https://lnkd.in/giWDYi9Y Rx only. Risk: peninc.info/risk Clinical results may vary.
-
-
US HCPs: We're just an hour away! Join us soon to explore how MIDWAY intermediate catheters are engineered for trackability, support, and stable access for ever-evolving therapies. Haven't registered yet? There's still time! https://lnkd.in/giWDYi9Y Rx only. Risk: peninc.info/risk Clinical results may vary.
-
-
Don’t miss our FLIP trivia event at SNIS on July 24th at 5:30 PM! Join Dr. Don Frei for an interactive dinner on thrombectomy techniques for fellows & residents! Register here or find us at booth #501 to save your spot! https://lnkd.in/g5Kjf7jH #FellowsLeapingIntoPractice
-
-
Penumbra, Inc. reposted this
US HCPs: #NOWISTHETIME Welcome #MIDWAY Intermediate Catheters - designed to strike the balance of trackability & stability. Learn more about our latest iterations of our advanced access technology at #SNIS2024 Rx only. Risk info: peninc.info/riskClinical results may vary
-
US HCPs: Tomorrow is the day! Don't miss our webinar on how MIDWAY intermediate catheters are designed to reshape neurovascular procedures. Register now! https://lnkd.in/giWDYi9Y Rx only. Risk: peninc.info/risk Clinical results may vary.
US HCPs: Are MIDWAY intermediate catheters reshaping neurovascular procedures? Join our webinar with Dr. John C. Chaloupka and Dr. Ben Yim as they share their journey with intermediate catheters. Discover the purpose-built design that optimizes trackability, support, and stable access for ever-evolving therapies. Sign up now to learn how MIDWAY may expand procedural possibilities! Register here: https://lnkd.in/giWDYi9Y Rx only. Risk: peninc.info/risk Clinical results may vary
-
-
ICYMI: Dive into the innovative PERT approach for acute PE management with Dr. Robert Lookstein, interviewed by Dr. Christopher Beck from BackTable Vascular and Interventional Podcast. Listen here: https://lnkd.in/gijKuSfS #CAVT #MedTech #Innovation
-
Yesterday, we hosted doctors visiting us all the way from APAC countries, sharing insights about how our latest #CAVT technology could improve patient care around the world. #NowIsTheTime #PenumbraProud #MedTech #Innovation
-
-
Penumbra, Inc. reposted this
THIS WEEK: Don't miss our webinar happening this Thursday, July 11th! This webinar, supported by Penumbra, Inc., will be moderated by AVF Leader Dr. Kathleen Ozsvath, featuring a number of other excellent faculty as speakers. Register now! https://lnkd.in/gaepj-2W
-
-
US HCPs: Are MIDWAY intermediate catheters reshaping neurovascular procedures? Join our webinar with Dr. John C. Chaloupka and Dr. Ben Yim as they share their journey with intermediate catheters. Discover the purpose-built design that optimizes trackability, support, and stable access for ever-evolving therapies. Sign up now to learn how MIDWAY may expand procedural possibilities! Register here: https://lnkd.in/giWDYi9Y Rx only. Risk: peninc.info/risk Clinical results may vary
-